ALNY

NASDAQStock

Alnylam Pharmaceuticals, Inc.

$313.45-3.77 (-1.19%)

52-Week Range

$224.32
$491.22

Key Stats

Market Cap

41.6B

P/E Ratio

155.95

Dividend Yield

Beta

0.38

Volume

526.0K

Avg Volume

1.5M

Performance

1M

+2.84%

3M

-18.97%

6M

-31.21%

YTD

-20.73%

1Y

+31.22%

3Y

+70.78%

5Y

+117.10%

Price Chart

ETF Exposure

ALNY is held by 460 ETFs

ETFFund NameWeight
LCTUiShares U.S. Carbon Transition Readiness Aware Active ETF0.08%
ESGVVanguard ESG U.S. Stock ETF0.08%
STRVStrive 500 ETF0.08%
USAC.PAAmundi MSCI USA ESG Broad Transition UCITS ETF Acc0.08%
XOUTGraniteShares XOUT U.S. Large Cap ETF0.08%
ESGW.LInvesco MSCI World Universal Screened UCITS ETF0.08%
ESGW.SGInvesco MSCI World ESG Universal Screened UCITS ETF0.08%
VVVanguard Large-Cap ETF0.08%
XRME.FXtrackers MSCI USA ESG Screened UCITS ETF0.08%
XRSS.LXtrackers MSCI USA Screened UCITS ETF 1C0.08%
MXUD.LInvesco MSCI USA UCITS ETF0.08%
SC0H.DEInvesco MSCI USA UCITS ETF0.08%
DRMU.TODesjardins RI USA - Net-Zero Emissions Pathway ETF0.08%
GPSA.LiShares MSCI USA Screened UCITS ETF0.07%
SLUS.DEiShares MSCI USA Screened UCITS ETF0.07%
UB0A.LUBS Core MSCI USA UCITS ETF hGBP acc0.07%
BKLCBNY Mellon US Large Cap Core Equity ETF0.07%
GSUSGoldman Sachs MarketBeta U.S. Equity ETF0.07%
JUSTGoldman Sachs JUST U.S. Large Cap Equity ETF0.07%
ONOFGlobal X - Adaptive U.S. Risk Management ETF0.07%
USCHWH.SWUBS Core MSCI USA hCHF UCITS ETF CHF acc0.07%
GXLCGlobal X - U.S. 500 ETF0.07%
WPAB.SWiShares MSCI World Paris-Aligned Climate UCITS ETF0.07%
CSY1.DEUBS MSCI USA NSL UCITS ETF USD acc0.07%
IUME.ASiShares MSCI USA Momentum Factor Advanced UCITS ETF0.07%
NTSX.LWisdomTree US Efficient Core UCITS ETF - USD Acc0.07%
NTSX.MIWisdomTree US Efficient Core UCITS ETF - USD Acc0.07%
PBUSInvesco MSCI USA ETF0.07%
SFLRInnovator Equity Managed Floor ETF0.07%
UC03.LUBS Core MSCI USA UCITS ETF USD dis0.07%
UC04.LUBS Core MSCI USA UCITS ETF USD dis0.07%
XD9D.DEXtrackers MSCI USA UCITS ETF 1D0.07%
XD9U.DEXtrackers MSCI USA UCITS ETF 1C0.07%
XD9U.LXtrackers MSCI USA UCITS ETF 1C0.07%
XDUS.LXtrackers MSCI USA UCITS ETF 1C0.07%
BBDD.LJPMorgan ETFs (Ireland) ICAV - BetaBuilders US Equity UCITS ETF0.07%
BBSU.LJPMorgan ETFs (Ireland) ICAV - BetaBuilders US Equity UCITS ETF0.07%
BBUSJPMorgan BetaBuilders U.S. Equity ETF0.07%
BBUS.DEJPMorgan ETFs (Ireland) ICAV - BetaBuilders US Equity UCITS ETF0.07%
BBUS.LJPMorgan ETFs (Ireland) ICAV - BetaBuilders US Equity UCITS ETF0.07%
CU1.LiShares MSCI USA UCITS ETF0.07%
FXUS.MEFinEx MSCI USA UCITS ETF USD Share Class0.07%
ISMCFiShares MSCI USA UCITS ETF0.07%
DFUSDimensional - US Equity Market ETF0.07%
ILCBiShares Morningstar U.S. Equity ETF0.07%
JKDiShares Morningstar U.S. Equity ETF0.07%
SCHXSchwab U.S. Large-Cap ETF0.07%
VNRA.DEVanguard FTSE North America UCITS ETF (USD) Accumulating0.07%
VOTETCW Transform 500 ETF0.07%
DFAUDimensional - US Core Equity Market ETF0.07%
PreviousPage 6 of 10Next

About ALNY ETF Exposure

Alnylam Pharmaceuticals, Inc. (ALNY) is held by 460 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 41.6B, ALNY is a widely held institutional stock. The stock currently trades at $313.45. Investors can gain exposure to ALNY through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ALNY, sorted by portfolio weight.